Business
Mankind Pharma reports net profit jump of 37.7 percent in September quarter
Reported by Vivek Joshi (Copy Editor) · Economic Times - Markets ·
Reported by one source so far
Mankind Pharma posted a net profit of ₹716 crore for the September quarter, marking a 37.7 percent rise compared to the same period last year. Revenue from operations went up to ₹4,337.9 crore, moving up from ₹3,697.2 crore a year ago.
Growth Factors
The company states that this financial growth came from strong sales in both the home market and overseas markets. Its recent purchase of Armed Cell Therapeutics aims to boost its research and development strength.
Context
Corporate earnings reports help investors track how well major drug makers and other large companies perform over three-month business cycles. Such quarterly updates reflect broader business health across the pharma sector.
More in Business
BusinessExplainerVerified — Confirmed by a second source: Google News - USA BusinessMajor
Honda Executive Warns Canada Tariff Hike Would Devastate Auto Industry.
Reported by Danish Ansari (Fact-Checker) · CNBC - Top News ·
BusinessUnconfirmed — Reported by one source so farImportant
Mallika Srinivasan and Lakshmi Venu push for settlement as TVS relatives file court caveats
Reported by Tanvi Pillai (Section Editor) · Indian Express - Business ·
BusinessUnconfirmed — Reported by one source so farImportant
Private sector banks face higher bad-loan pressure as unsecured lending grows, says Icra report.
Reported by Deepak Mishra (Copy Editor) · The Hindu - Business ·
